SANJEEV VASUDEVAN to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications SANJEEV VASUDEVAN has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.212
-
Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling. Cancer Lett. 2019 08 10; 457:129-141.
Score: 0.097
-
Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children's Oncology Group study ARST0332. Cancer. 2024 Aug 01; 130(15):2683-2693.
Score: 0.034
-
Congenital spindle cell rhabdomyosarcoma. Pediatr Blood Cancer. 2019 11; 66(11):e27935.
Score: 0.024
-
p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy. Clin Cancer Res. 2017 Nov 01; 23(21):6629-6639.
Score: 0.021
-
Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma. Oncotarget. 2017 Jan 03; 8(1):1555-1568.
Score: 0.020
-
Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in children. J Pediatr Surg. 2012 Jun; 47(6):1261-6.
Score: 0.015